Quantitative immunohistochemistry in lung cancer: clinical perspective.

Quantitative immunohistochemistry in lung cancer: clinical perspective.

Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of...

Full description

Bibliographic Details
Main Authors: Rafał Dziadziuszko, Ewa Szutowicz
Format: Article
Language:English
Published: Via Medica 2010-06-01
Series:Folia Histochemica et Cytobiologica
Online Access:http://czasopisma.viamedica.pl/fhc/article/view/4252
id doaj-4fa6aa50f5804d79b2f69cfad7283899
record_format Article
spelling doaj-4fa6aa50f5804d79b2f69cfad72838992020-11-25T00:09:30ZengVia MedicaFolia Histochemica et Cytobiologica0239-85081897-56312010-06-0148171110.5603/4252Quantitative immunohistochemistry in lung cancer: clinical perspective.Rafał DziadziuszkoEwa SzutowiczQuantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of treatment benefit. Several of these markers are currently explored in phase II-III clinical studies to individualize the treatment of lung cancer.http://czasopisma.viamedica.pl/fhc/article/view/4252
collection DOAJ
language English
format Article
sources DOAJ
author Rafał Dziadziuszko
Ewa Szutowicz
spellingShingle Rafał Dziadziuszko
Ewa Szutowicz
Quantitative immunohistochemistry in lung cancer: clinical perspective.
Folia Histochemica et Cytobiologica
author_facet Rafał Dziadziuszko
Ewa Szutowicz
author_sort Rafał Dziadziuszko
title Quantitative immunohistochemistry in lung cancer: clinical perspective.
title_short Quantitative immunohistochemistry in lung cancer: clinical perspective.
title_full Quantitative immunohistochemistry in lung cancer: clinical perspective.
title_fullStr Quantitative immunohistochemistry in lung cancer: clinical perspective.
title_full_unstemmed Quantitative immunohistochemistry in lung cancer: clinical perspective.
title_sort quantitative immunohistochemistry in lung cancer: clinical perspective.
publisher Via Medica
series Folia Histochemica et Cytobiologica
issn 0239-8508
1897-5631
publishDate 2010-06-01
description Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of treatment benefit. Several of these markers are currently explored in phase II-III clinical studies to individualize the treatment of lung cancer.
url http://czasopisma.viamedica.pl/fhc/article/view/4252
work_keys_str_mv AT rafałdziadziuszko quantitativeimmunohistochemistryinlungcancerclinicalperspective
AT ewaszutowicz quantitativeimmunohistochemistryinlungcancerclinicalperspective
_version_ 1725411565281214464

Similar Items